These results are consistent with the presence of increased circulating levels of chemerin in patients with hypertension [90,125,154,155], where chemerin correlates with inflammatory markers such as TNFα, CRP, and IL-6; metabolic syndrome; and adipose tissue accumulation [90,125,154]. This evidence concerns the gene RARRES2 and metabolic syndrome.